Jonah Comstock

Dr Michael Bauer on Quantro’s mission to drug the “undruggable” Nearly two years on from their first meeting at JP Morgan 2025, pharmaphorum editor-in-chief Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss... See more

Changing Faces: Board of Director and Advisory Board hires, August 2026 Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August, with companies across biotech, diagnostics, digital health, and life sciences services bringing in ... See more

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's oral selective oestrogen receptor degrader (SERD) imlunestrant (Inluriyo), has received a second FDA approval, this time in combination with CDK4/6 inhibitor abemaciclib (Verzenio), ano... See more

Policy in Focus: What’s new with CMS drug price negotiation, with Alice Valder Curran The drug price negotiation provisions in the Inflation Reduction Act were designed to continue evolving with each passing year. As CMS prepares for 2028 and 2029, the ag... See more

Changing Faces: Boards of Directors and Advisory Boards, May 2026 Board-level appointments across biotech, biopharma, and industry organisations continued at pace over the period, with companies bringing in seasoned executives and governance experts to gu... See more